Mixed reports: several studies identify increased ANXA1 transcripts in CD lesion panels and as part of diagnostic gene sets; functional work suggests defective AnxA1 secretion (non-conventional/ABC transporter) in CD that impairs FPR2 signaling (94, 124). This evidence concerns the gene FPR2 and Cowden disease.